Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2015

Feb 18, 2015

30016_dirs_2015-02-18_238fbbf7-3040-475e-8dd1-5a65afaed558.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-02-14

Reporting Person: MAZELSKY JAY (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-14 Common Stock M 202 Acquired 3612 Direct
2015-02-14 Common Stock M 273 Acquired 3885 Direct
2015-02-14 Common Stock F 176 $159.08 Disposed 3709 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-14 Non-Qualified Stock Option (right to buy) $159.08 A 13424 Acquired 2025-02-13 Common Stock (13424) Direct
2015-02-14 Incentive Stock Option (right to buy) $159.08 A 628 Acquired 2025-02-13 Common Stock (628) Direct
2015-02-14 Restricted Stock Unit $ A 1179 Acquired Common Stock (1179) Direct
2015-02-14 Restricted Stock Unit $ M 202 Disposed Common Stock (202) Direct
2015-02-14 Restricted Stock Unit $ M 273 Disposed Common Stock (273) Direct

Footnotes

F1: Includes 44 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 12/31/2014.

F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that becomes exercisable as to 2,811 shares on 02/14/2016 and 02/14/2017, 2,810 shares on 02/14/2018 and 02/14/2019, and the remaining 2,182 shares on 02/14/2020.

F3: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests on the fifth anniversary date (02/14/2020) of the grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2016) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2015) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.